Kalshi to launch markets on clinical trials and FDA review outcomes

The prediction platform says the pilot will let traders bet on late-stage drug trial results and FDA decisions using predefined public-document criteria.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.